Larvol Delta - SPARK-SBRT-Combined-With-ReducedDose-Anthracycline-Chemotherapy-and-Toripalimab-as-Neoadjuvant-Therapy-for-Localized-HighRisk-Undifferentiated-Pleomorphic-Sarcoma

Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Bioscience, Coherus Oncology

http://clinicaltrials.gov/ct2/show/NCT07817095

Sep 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next